BIODEXA PHARMACEUTICALS-ADR (BDRX) Institutional Ownership and Insiders Activity
BIODEXA PHARMACEUTICALS-ADR (BDRX) is widely held by institutional investors, with 6 firms reporting positions valued at approximately $9,604 based on SEC Form 13F filings for the quarter ended September 30, 2026.
Stonex Group Inc. is the largest disclosed holder, reporting approximately $8,373 in BDRX holdings in its latest filing.
Institutional ownership remains highly concentrated, with Stonex Group Inc. representing the majority of disclosed value.
Institutional Holders
6
Total Reported Value
$9,604
Largest Holder
Stonex Group Inc.
Largest Position
$8,373
Insider Transactions (90d)
0
Latest Filing Quarter
Q3 2026
New Institutional Positions
5
Funds Exiting Positions
0
Top Institutional Owners
View allInvestorReported Balance
Related BDRX Institutional Insights:
- BDRX 13F Institutional Holders
- BDRX Superinvestors
- BDRX Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BDRX Insider Trading & SEC Form 4 Activity
- BDRX Articles
- Top Institutional Investor Stock Rankings